vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $23.6M, roughly 1.6× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -161.8%, a 176.4% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-71.3M).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
GENC vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $38.3M |
| Net Profit | $3.4M | $-61.9M |
| Gross Margin | 28.7% | 99.0% |
| Operating Margin | 13.2% | -169.0% |
| Net Margin | 14.6% | -161.8% |
| Revenue YoY | -25.0% | 407.0% |
| Net Profit YoY | -9.8% | -4.7% |
| EPS (diluted) | $0.23 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $38.3M | ||
| Q3 25 | $18.8M | $32.1M | ||
| Q2 25 | $27.0M | $26.4M | ||
| Q1 25 | $38.2M | $16.5M | ||
| Q4 24 | $31.4M | $7.6M | ||
| Q3 24 | $20.9M | $6.1M | ||
| Q2 24 | $25.6M | — | ||
| Q1 24 | $40.7M | — |
| Q4 25 | $3.4M | $-61.9M | ||
| Q3 25 | $1.9M | $-67.3M | ||
| Q2 25 | $3.8M | $-92.6M | ||
| Q1 25 | $6.1M | $-129.6M | ||
| Q4 24 | $3.8M | $-59.2M | ||
| Q3 24 | $1.5M | $-85.7M | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $6.2M | — |
| Q4 25 | 28.7% | 99.0% | ||
| Q3 25 | 24.2% | 99.4% | ||
| Q2 25 | 26.5% | 99.5% | ||
| Q1 25 | 29.7% | 99.6% | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 25.6% | — | ||
| Q2 24 | 23.9% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | 13.2% | -169.0% | ||
| Q3 25 | -1.2% | -173.5% | ||
| Q2 25 | 11.6% | -269.8% | ||
| Q1 25 | 17.0% | -390.1% | ||
| Q4 24 | 14.7% | -919.0% | ||
| Q3 24 | 5.9% | -1314.3% | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 17.4% | — |
| Q4 25 | 14.6% | -161.8% | ||
| Q3 25 | 10.2% | -209.8% | ||
| Q2 25 | 14.2% | -350.3% | ||
| Q1 25 | 16.0% | -784.9% | ||
| Q4 24 | 12.1% | -783.4% | ||
| Q3 24 | 6.9% | -1404.0% | ||
| Q2 24 | 10.0% | — | ||
| Q1 24 | 15.3% | — |
| Q4 25 | $0.23 | $-0.06 | ||
| Q3 25 | $0.13 | $-0.07 | ||
| Q2 25 | $0.26 | $-0.10 | ||
| Q1 25 | $0.42 | $-0.15 | ||
| Q4 24 | $0.26 | $-0.08 | ||
| Q3 24 | $0.10 | $-0.14 | ||
| Q2 24 | $0.17 | — | ||
| Q1 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $-500.5M |
| Total Assets | $228.9M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | $242.8M | ||
| Q3 25 | $136.3M | $257.8M | ||
| Q2 25 | $136.0M | $153.7M | ||
| Q1 25 | $143.7M | $61.6M | ||
| Q4 24 | $130.1M | $149.8M | ||
| Q3 24 | $115.4M | $130.4M | ||
| Q2 24 | $116.6M | — | ||
| Q1 24 | $117.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | $-500.5M | ||
| Q3 25 | $211.8M | $-524.3M | ||
| Q2 25 | $209.9M | $-570.7M | ||
| Q1 25 | $206.1M | $-591.4M | ||
| Q4 24 | $200.0M | $-489.1M | ||
| Q3 24 | $196.1M | $-745.1M | ||
| Q2 24 | $194.7M | — | ||
| Q1 24 | $192.1M | — |
| Q4 25 | $228.9M | $501.9M | ||
| Q3 25 | $222.6M | $519.0M | ||
| Q2 25 | $220.2M | $402.1M | ||
| Q1 25 | $223.9M | $303.8M | ||
| Q4 24 | $218.2M | $382.9M | ||
| Q3 24 | $208.1M | $364.6M | ||
| Q2 24 | $201.8M | — | ||
| Q1 24 | $206.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $-70.4M |
| Free Cash FlowOCF − Capex | $10.1M | $-71.3M |
| FCF MarginFCF / Revenue | 43.0% | -186.2% |
| Capex IntensityCapex / Revenue | 4.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $-70.4M | ||
| Q3 25 | $-275.0K | $-68.9M | ||
| Q2 25 | $-23.9M | $-79.7M | ||
| Q1 25 | $12.4M | $-85.9M | ||
| Q4 24 | $14.8M | $-85.1M | ||
| Q3 24 | $-3.2M | $-98.8M | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | $10.1M | $-71.3M | ||
| Q3 25 | $-1.3M | $-69.6M | ||
| Q2 25 | $-24.4M | $-80.8M | ||
| Q1 25 | $12.3M | $-87.0M | ||
| Q4 24 | $14.5M | $-87.3M | ||
| Q3 24 | $-3.3M | $-101.6M | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | 43.0% | -186.2% | ||
| Q3 25 | -6.8% | -217.2% | ||
| Q2 25 | -90.4% | -305.9% | ||
| Q1 25 | 32.2% | -526.9% | ||
| Q4 24 | 46.1% | -1155.4% | ||
| Q3 24 | -15.8% | -1663.2% | ||
| Q2 24 | -5.6% | — | ||
| Q1 24 | 28.7% | — |
| Q4 25 | 4.1% | 2.4% | ||
| Q3 25 | 5.4% | 2.3% | ||
| Q2 25 | 1.8% | 4.1% | ||
| Q1 25 | 0.4% | 6.8% | ||
| Q4 24 | 1.0% | 28.0% | ||
| Q3 24 | 0.4% | 45.7% | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | — | ||
| Q1 24 | 1.87× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
